Skip to main content
73°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Unicycive Therapeutics Inc
(NQ:
UNCY
)
0.3780
-0.0020 (-0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Unicycive Therapeutics Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via
Benzinga
The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
March 06, 2023
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company spearheading efforts to develop effective, safe, and novel treatments for kidney disease to improve patient and caregiver...
Via
Benzinga
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
March 06, 2023
Via
Benzinga
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
March 03, 2023
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
Via
News Direct
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers
March 02, 2023
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company committed to developing effective and safe treatments for kidney (renal) disease to reduce death rates and improve patients and...
Via
Benzinga
Unicycive: The Company Developing Key Kidney Therapies
February 17, 2023
by\nJohnny Rice, Benzinga Contributor
Via
News Direct
Unicycive Therapeutics' Geographic Atrophy Candidate Shows Improved Contrast Vision In Animal Studies
November 21, 2022
Via
Benzinga
Unicycive Inks Licensing Pact For Its Kidney Disease Candidate In China
July 18, 2022
Via
Benzinga
Unicycive: The Company Developing Key Kidney Therapies
February 16, 2023
Doug Jermasek, Executive Vice President, Corporate Strategy for Unicycive Therapeutics, Inc. (NASDAQ: UNCY), was recently interviewed by Benzinga.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 07, 2023
Via
Benzinga
Unicycive: This Biotech Company Receives Promising Results From New Trial
February 06, 2023
Unicycive: This Biotech Company Receives Promising Results From New Trial
Via
News Direct
Unicycive: This Biotech Company Receives Promising Results From New Trial
February 03, 2023
Unicycive Therapeutics Inc. (NASDAQ: UNCY) is a biotechnology company developing drug candidates currently focused on kidney disease. The innovative treatments may have vast potential outside of the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 06, 2023
Via
Benzinga
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
January 03, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 29, 2022
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
December 29, 2022
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the...
Via
Benzinga
Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher
December 28, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.
Via
Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
December 28, 2022
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 28, 2022
Via
Benzinga
Dow Tumbles 150 Points; Crude Oil Falls Sharply
December 28, 2022
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.
Via
Benzinga
Unicycive Shares Jump As Renazorb Achieves Primary Endpoint In Bioequivalence Study
December 28, 2022
Via
Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
December 07, 2022
In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 04, 2022
Gainers
Via
Benzinga
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 12, 2022
By David Willey, Benzinga
Via
News Direct
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 11, 2022
You may remember learning that mitochondria are the powerhouse of the cells, but do you know the dangers that result if these cell superheroes get sick?
Via
Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 22, 2022
Most people are surprised to learn that chronic kidney disease (CKD) is the fastest growing, non-communicable disease in the United States. 37 million American adults have CKD and more than 600,000...
Via
Benzinga
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.